Nuvectis Pharma Balance Sheet Health
Financial Health criteria checks 6/6
Nuvectis Pharma has a total shareholder equity of $12.2M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $19.2M and $7.0M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$19.13m |
Equity | US$12.20m |
Total liabilities | US$6.98m |
Total assets | US$19.19m |
Recent financial health updates
Is Nuvectis Pharma (NASDAQ:NVCT) In A Good Position To Deliver On Growth Plans?
Jan 06Here's Why We're Not Too Worried About Nuvectis Pharma's (NASDAQ:NVCT) Cash Burn Situation
Oct 03We're Not Very Worried About Nuvectis Pharma's (NASDAQ:NVCT) Cash Burn Rate
Jan 31We're Keeping An Eye On Nuvectis Pharma's (NASDAQ:NVCT) Cash Burn Rate
May 04Recent updates
Is Nuvectis Pharma (NASDAQ:NVCT) In A Good Position To Deliver On Growth Plans?
Jan 06Here's Why We're Not Too Worried About Nuvectis Pharma's (NASDAQ:NVCT) Cash Burn Situation
Oct 03We're Not Very Worried About Nuvectis Pharma's (NASDAQ:NVCT) Cash Burn Rate
Jan 31Nuvectis Pharma forms scientific advisory board for research and development of drugs
Sep 28Nuvectis Pharma GAAP EPS of -$0.28 misses by $0.04
Aug 05Nuvectis Pharma declines 13%, announces $15.9M private placement
Jul 27We're Keeping An Eye On Nuvectis Pharma's (NASDAQ:NVCT) Cash Burn Rate
May 04Financial Position Analysis
Short Term Liabilities: NVCT's short term assets ($19.2M) exceed its short term liabilities ($7.0M).
Long Term Liabilities: NVCT has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: NVCT is debt free.
Reducing Debt: NVCT has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: NVCT has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: NVCT has sufficient cash runway for 1.1 years if free cash flow continues to reduce at historical rates of 42.1% each year.